Cargando…
Anti-Leukemia Activity of MS-275 Histone Deacetylase Inhibitor Implicates 4-1BBL/4-1BB Immunomodulatory Functions
Histone deacetylase inhibitors (HDACi) have demonstrated promising therapeutic potential in clinical trials for hematological malignancies. HDACi, such as SAHA/Vorinostat, Trichostatin A, and MS-275 were found to induce apoptosis of leukemic blasts through activation of the death receptor pathway an...
Autores principales: | Vire, Bérengère, de Walque, Stéphane, Restouin, Audrey, Olive, Daniel, Van Lint, Carine, Collette, Yves |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2738963/ https://www.ncbi.nlm.nih.gov/pubmed/19759901 http://dx.doi.org/10.1371/journal.pone.0007085 |
Ejemplares similares
-
The TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responses
por: Barao, Isabel
Publicado: (2013) -
Blockade of 4-1BB and 4-1BBL Interaction Reduces Obesity-Induced Skeletal Muscle Inflammation
por: Le, Ngoc Hoan, et al.
Publicado: (2013) -
The involvement of 4‐1BB/4‐1BBL signaling in glial cell‐mediated hypothalamic inflammation in obesity
por: Kim, Jiye, et al.
Publicado: (2018) -
Structure of the 4-1BB/4-1BBL complex and distinct binding and functional properties of utomilumab and urelumab
por: Chin, S. Michael, et al.
Publicado: (2018) -
Galectin-3 Decreases 4-1BBL Bioactivity by Crosslinking Soluble and Membrane Expressed 4-1BB
por: Nielsen, Morten Aagaard, et al.
Publicado: (2022)